FIELD: ophthalmology.
SUBSTANCE: main composition contains: (a) ketotifen fumarate to the concentration in calculation to free ketotifen from approx. 0.01 mas. % to approx. 0.1 mas.%;(b) source of hydrogen peroxide ensuring presence of hydrogen peroxide with trace quantities amounting from approximately 0.001 to approximately 0.1% (mas./vol.); (c) one or several stabilizers of hydrogen peroxide compatible with eyes; (d) hypromellose to the concentration from approximately 0.005 mas% to approximately 0.5 mas.%; and (e) sodium carboxymethyl cellulose to the concentration from approx. 0.005 mas.% to approx 0.5 mas.%. At this the value of composition pH amounts to approximately from 4.0 to 5.3.
EFFECT: invention is a method of treatment and prevention of allergic conjunctivitis which is ensured with application locally in the effective quantity of the mentioned eye composition to person with allergic conjunctivitis or sensitive to it.
13 cl, 15 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STABILISED OPHTHALMIC COMPOSITIONS OF KETOTIFEN CONTAINING PRESERVING AGENT | 2006 |
|
RU2444361C2 |
| KETOTHIPHEN-CONTAINING OPHTHALMIC COMPOSITION | 2000 |
|
RU2248789C2 |
| LOW-DOSE BRIMONIDINE COMBINATIONS AND THEIR USE | 2018 |
|
RU2801221C2 |
| WAYS OF CONSERVATION OF OPHTHALMOLOGIC SOLUTIONS AND CONSERVED OPHTHALMOLOGIC SOLUTIONS | 2003 |
|
RU2359706C2 |
| COMPOSITIONS AND METHODS USED FOR DECREASING OCULAR HYPERTENSION | 1998 |
|
RU2197970C2 |
| OPHTHALMIC COMPOSITIONS WITH IMPROVED DESSICATION PROTECTION AND RETENTION | 2013 |
|
RU2659207C2 |
| APPLICATION OF RIMEXOLONE FOR DRY EYE SYNDROME TREATMENT | 2003 |
|
RU2330668C2 |
| METHODS AND COMPOSITIONS FOR TREATING PRESBYOPIA, MYDRIASIS AND OTHER OCULAR DISORDERS | 2019 |
|
RU2824137C2 |
| APPLICATION OF BENZTROPINE TO ABORT PROGRESSION OF AXIAL MYOPIA IN HUMANS | 2017 |
|
RU2793238C2 |
| TREATMENT OF ALLERGIC RHINITIS IN PEDIATRIC CATEGORY USING A COMBINATION OF MOMETASONE AND OLOPATADINE | 2019 |
|
RU2798030C2 |
